<code id='16094C3CF3'></code><style id='16094C3CF3'></style>
    • <acronym id='16094C3CF3'></acronym>
      <center id='16094C3CF3'><center id='16094C3CF3'><tfoot id='16094C3CF3'></tfoot></center><abbr id='16094C3CF3'><dir id='16094C3CF3'><tfoot id='16094C3CF3'></tfoot><noframes id='16094C3CF3'>

    • <optgroup id='16094C3CF3'><strike id='16094C3CF3'><sup id='16094C3CF3'></sup></strike><code id='16094C3CF3'></code></optgroup>
        1. <b id='16094C3CF3'><label id='16094C3CF3'><select id='16094C3CF3'><dt id='16094C3CF3'><span id='16094C3CF3'></span></dt></select></label></b><u id='16094C3CF3'></u>
          <i id='16094C3CF3'><strike id='16094C3CF3'><tt id='16094C3CF3'><pre id='16094C3CF3'></pre></tt></strike></i>

          leisure time

          leisure time

          author:comprehensive    Page View:6349
          Richard Burr
          North Carolina Senator Richard Burr received strong support from the biotech sector. Gerry Broome/AP

          WASHINGTON — A veteran senator and champion of the biotech sector beat back an unusually strong challenge Tuesday night — thanks in large part to loyal support from the industry.

          North Carolina Senator Richard Burr, a Republican who has long protected the bioscience companies that drive his state’s economy, overcame a surprisingly robust challenge from Democratic candidate Deborah K. Ross.

          advertisement

          Burr, now finishing his second term in the Senate, serves on committees with oversight of both the Food and Drug Administration and Medicare and Medicaid. He is also chairman of the Select Committee on Intelligence.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          Medicare Advantage enrollment grows 7.1% to 33.4 million people
          Medicare Advantage enrollment grows 7.1% to 33.4 million people

          PabloMartinezMonsivais/APRoughly33.4millionadultsolderthan65andpeoplewithdisabilitieswereenrolledina

          read more
          The high cost of giving birth even with insurance
          The high cost of giving birth even with insurance

          AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

          read more

          Biden's Plan B on student loan forgiveness relies on Higher Education Act: What to know

          2:59PresidentJoeBidenspeaksabouthisplansforcontinuedstudentdebtreliefafteraU.S.SupremeCourtdecisionb